RxDoctor Payments Data

Jennifer Hough

Nurse Practitioner · Wake Forest, NCNPI 1497746580

Payments from drug & device makers

$1,022in general payments, 2019–2025

Across 29 payments — averaging $35.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$278
  • Nevro Corp.$178
  • Collegium Pharmaceutical, Inc.$103
  • AbbVie$90
  • Saluda Medical Americas, Inc.$82
  • Nalu Medical, Inc.$70
  • plus $221 from 10 others

What the payments were for

  • Food & beverage$1,022100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,022 in reported general payments places this provider in the 75th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$25,044
Medicare patients
142
Services billed
581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levorphanol Tartrate17$34,243
NucyntaTapentadol Hcl21$17,070
OxycontinOxycodone Hcl31$14,261
Emgality PenGalcanezumab-Gnlm12$8,703
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen376$7,131
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen255$4,263
Gabapentin140$3,240
Buprenorphine16$2,371
Tramadol Hcl ErTramadol Hcl25$2,157
Morphine Sulfate ErMorphine Sulfate99$2,085
Oxycodone Hcl145$2,017
Pregabalin126$1,847
Lidocaine14$1,651
Duloxetine Hcl83$1,530
Fentanyl22$1,478

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta$103$17,07021 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Wake Forest

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →